Invesco Ltd. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-10 11:32 am Sale |
2022-03-10 | 13G | Reata Pharmaceuticals, Inc. RETA |
Invesco Ltd. IVZ |
372,165 1.200% |
-1,908,244 (-83.68%) |
Filing |
| 2022-02-10 11:32 am Sale |
2022-02-09 | 13G | Reata Pharmaceuticals, Inc. RETA |
Invesco Ltd. IVZ |
2,280,409 7.200% |
-1,157,169 (-33.66%) |
Filing |
| 2021-09-10 10:22 am Purchase |
2021-09-10 | 13G | Reata Pharmaceuticals, Inc. RETA |
Invesco Ltd. IVZ |
3,437,578 10.900% |
1,658,103 (+93.18%) |
Filing |
| 2021-02-12 6:48 pm Purchase |
2021-02-12 | 13G | Reata Pharmaceuticals, Inc. RETA |
Invesco Ltd. IVZ |
1,779,475 5.700% |
1,779,475 (New Position) |
Filing |